Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data.The rapid updates are supported by an evidence
Authors
- Andreas Felix Hottinger (ORCID: https://orcid.org/0000-0001-7098-9414)
- Na Tosha Gatson (ORCID: https://orcid.org/0000-0003-1881-3520)
- Martin J. van den Bent (ORCID: https://orcid.org/0000-0001-5710-5127)
- Roy E. Strowd (ORCID: https://orcid.org/0000-0001-6651-5267)
- David Schiff (ORCID: https://orcid.org/0000-0002-1896-2502)
- Anne Shannon
- Jordan Morton (ORCID: https://orcid.org/0000-0002-9603-3768)
- Phioanh Leia Nghiemphu (ORCID: https://orcid.org/0000-0003-4064-6079)
- Hans J. Messersmith (ORCID: https://orcid.org/0000-0002-4585-9906)
- Helen Alice Shih (ORCID: https://orcid.org/0000-0003-1550-9726)
- Mateo Ziu (ORCID: https://orcid.org/0000-0002-3671-2638)
- Jaishri O. Blakeley (ORCID: https://orcid.org/0000-0002-1049-0993)
- Douglas Ney (ORCID: https://orcid.org/0000-0001-7273-8141)
- Andrew B. Lassman (ORCID: https://orcid.org/0000-0001-7386-9928)
- Nimish Mohile
- James Perry (ORCID: https://orcid.org/0000-0003-0698-6037)
Institutions
- American Society of Clinical Oncology (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Rochester Medical Center (US)
- University of Virginia Medical Center (US)
- Herbert Irving Comprehensive Cancer Center
- Columbia University (US)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1093/neuonc/noaf072
- Citations
- 3
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.88
Funders
- Abbott Laboratories
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Gilead Sciences
- American Society of Clinical Oncology
- Karyopharm Therapeutics
- Novocure
- Incyte
- Servier
- Genentech
- Foundation Medicine